A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors
Stopped The Principal Investigator left the institution.
Conditions
- Neuroepithelial Tumor
- Solid Tumor
- Allogeneic Hematopoietic Stem Cell Transplantation
Interventions
- PROCEDURE: Allogeneic hematopoietic stem cell transplant following thiotepa-based marrow ablative chemotherapy
- DRUG: Keratinocyte Growth Factor
- DRUG: Alemtuzumab
- DRUG: Thiotepa
- DRUG: Etoposide
- DRUG: Fludarabine
- DRUG: Melphalan
- DRUG: Tacrolimus
- DRUG: Cyclosporine A
- DRUG: Mycophenolate mofetil
Sponsor
Montefiore Medical Center
Collaborators
- [object Object]
- [object Object]